Linkage analysis identifies a locus for plasma von Willebrand factor undetected by genome-wide association

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 2, 2013, Pages 588-593

  Desch, Karl C ^a   Ozel, Ayse B ^b   Siemieniak, David ^c   Kalish, Yossi ^d   Shavit, Jordan A ^a   Thornburg, Courtney D ^e   Sharathkumar, Anjali A ^f   McHugh, Caitlin P ^g   Laurie, Cathy C ^g   Crenshaw, Andrew ^h   Mirel, Daniel B ^h   Kim, Yoonhee ⁱ   Cropp, Cheryl D ⁱ   Molloy, Anne M ^j   Kirke, Peadar N ^l   Bailey Wilson, Joan E ⁱ   Wilson, Alexander F ⁱ   Mills, James L ^m   Scott, John M ^k   Brody, Lawrence C ⁱ   Lib, Jun Z ^b   Ginsburg, David ^a,b,c   more..

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^e DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g UNIVERSITY OF WASHINGTON   (United States)

^h BROAD INSTITUTE OF MIT AND HARVARD   (United States)

ⁱ NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^j TRINITY COLLEGE DUBLIN   (Ireland)

^k TRINITY COLLEGE DUBLIN   (Ireland)

^l HEALTH RESEARCH BOARD   (Ireland)

^m EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

more..

Author keywords

Genome wide association study; Linkage study; Quantitative trait loci; Venous thromboembolic disease; Von Willebrand disease

Indexed keywords

VON WILLEBRAND FACTOR;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CHROMOSOME 2P; CHROMOSOME 2P13; CHROMOSOME 2Q; CHROMOSOME 2Q12; COHORT ANALYSIS; ENVIRONMENTAL FACTOR; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC TRAIT; HUMAN; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOSIS;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; ADULT; AGE FACTORS; CHROMOSOMES, HUMAN, PAIR 2; CHROMOSOMES, HUMAN, PAIR 9; COMPUTATIONAL BIOLOGY; GENE FREQUENCY; GENETIC LINKAGE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HAPLOTYPES; HUMANS; LOD SCORE; POLYMORPHISM, SINGLE NUCLEOTIDE; PRINCIPAL COMPONENT ANALYSIS; QUANTITATIVE TRAIT LOCI; SEX FACTORS; VON WILLEBRAND FACTOR;

EID: 84872180690     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1219885110     Document Type: Article

References (49)

1. Sadler JE (2005) von Willebrand factor: Two sides of a coin. J Thromb Haemost 3(8):1702-1709.
2. Nichols WL, et al. (2008) von Willebrand disease (VWD): Evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia 14(2):171-232.
3. Koster T, Blann AD, Briët E, Vandenbroucke JP, Rosendaal FR (1995) Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 345(8943):152-155.
4. Morange PE, et al.; PRIME Study Group (2004) Endothelial cell markers and the risk of coronary heart disease: The Prospective Epidemiological Study of Myocardial Infarction (PRIME) study. Circulation 109(11):1343-1348.
5. Wieberdink RG, et al. (2010) High von Willebrand factor levels increase the risk of stroke: The Rotterdam study. Stroke 41(10):2151-2156.
6. van Schie MC, et al. (2010) Active von Willebrand factor and the risk of stroke. Atherosclerosis 208(2):322-323.
7. Roldán V, et al. (2011) Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients. J Am Coll Cardiol 57(25):2496-2504.
8. de Lange M, et al. (2006) Genetic influences on fibrinogen, tissue plasminogen activator- antigen and von Willebrand factor in males and females. Thromb Haemost 95(3):414-419.
9. Jilma B, et al. (2005) High dose dexamethasone increases circulating P-selectin and von Willebrand factor levels in healthy men. Thromb Haemost 94(4):797-801.
10. Lip GY, Foster W, Blann AD (2005) Plasma von Willebrand factor levels and surrogates of atherosclerosis. J Thromb Haemost 3(4):659-661.
11. Goligorsky MS, Patschan D, Kuo MC (2009) Weibel-Palade bodies-Sentinels of acute stress. Nat Rev Nephrol 5(7):423-426.
12. Orstavik KH, et al. (1985) Factor VIII and factor IX in a twin population. Evidence for a major effect of ABO locus on factor VIII level. Am J Hum Genet 37(1):89-101.
13. de Lange M, Snieder H, Ariëns RA, Spector TD, Grant PJ (2001) The genetics of haemostasis: A twin study. Lancet 357(9250):101-105.
14. Bladbjerg EM, et al. (2006) Genetic influence on thrombotic risk markers in the elderly-A Danish twin study. J Thromb Haemost 4(3):599-607.
15. Souto JC, et al. (2003) Genome-wide linkage analysis of von Willebrand factor plasma levels: Results from the GAIT project. Thromb Haemost 89(3):468-474.
16. Gallinaro L, et al. (2008) A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor. Blood 111(7):3540-3545.
17. Canis K, et al. (2010) The plasma von Willebrand factor O-glycome comprises a surprising variety of structures including ABH antigens and disialosyl motifs. J Thromb Haemost 8(1):137-145.
18. Nossent AY, Vos HL, Rosendaal FR, Bertina RM, Eikenboom JC (2008) Aquaporin 2 gene variations, risk of venous thrombosis and plasma levels of von Willebrand factor and factor VIII. Haematologica 93(6):959-960.
19. Yamamoto F, McNeill PD, Hakomori S (1992) Human histo-blood group A2 transferase coded by A2 allele, one of the A subtypes, is characterized by a single base deletion in the coding sequence, which results in an additional domain at the carboxyl terminal. Biochem Biophys Res Commun 187(1):366-374.
20. Smith NL, et al.; Wellcome Trust Case Control Consortium (2010) Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium. Circulation 121(12):1382-1392.
21. Stone N, et al. (2011) Bioinformatic and genetic association analysis of microRNA target sites in one-carbon metabolism genes. PLoS ONE 6(7):e21851.
22. Desch K, et al. (2011) Analysis of informed consent document utilization in a minimalrisk genetic study. Ann Intern Med 155(5):316-322.
23. Mills JL, et al. (2011) Do high blood folate concentrations exacerbate metabolic abnormalities in people with low vitamin B-12 status? Am J Clin Nutr 94(2):495-500.
24. University of Michigan, Office of the Registrar (2010) Ethnicity of University of Michigan students. www.umich.edu/~regoff/enrollment/ethnicity.php. Accessed 11-14-2012.
25. Abecasis GR, Cherny SS, Cookson WO, Cardon LR (2002) Merlin-Rapid analysis of dense genetic maps using sparse gene fl ow trees. Nat Genet 30(1):97-101.
26. Yang J, Lee SH, Goddard ME, Visscher PM (2011) GCTA: A tool for genome-wide complex trait analysis. Am J Hum Genet 88(1):76-82.
27. Barbalic M, et al. (2010) Large-scale genomic studies reveal central role of ABO in sPselectin and sICAM-1 levels. Hum Mol Genet 19(9):1863-1872.
28. Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE (1997) Prospective study of hemostatic factors and incidence of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 96(4):1102-1108.
29. Feng D, et al. (2000) Factor VII gene polymorphism, factor VII levels, and prevalent cardiovascular disease: The Framingham Heart Study. Arterioscler Thromb Vasc Biol 20(2):593-600.
30. Chester MA, Olsson ML (2001) The ABO blood group gene: A locus of considerable genetic diversity. Transfus Med Rev 15(3):177-200.
31. Ahlen MT, et al. (2012) The development of severe neonatal alloimmune thrombocytopenia due to anti-HPA-1a antibodies is correlated to maternal ABO genotypes. Clin Dev Immunol 2012:156867.
32. Boyles AL, et al. (2005) Linkage disequilibrium inflates type I error rates in multipoint linkage analysis when parental genotypes are missing. Hum Hered 59(4):220-227.
33. Wiltshire S, Cardon LR, McCarthy MI (2002) Evaluating the results of genomewide linkage scans of complex traits by locus counting. Am J Hum Genet 71(5):1175-1182.
34. Antoni G, et al. (2011) Combined analysis of three genome-wide association studies on vWF and FVIII plasma levels. BMC Med Genet 12:102.
35. Zabaneh D, et al. (2011) Genetic variants associated with Von Willebrand factor levels in healthy men and women identified using the HumanCVD BeadChip. Ann Hum Genet 75(4):456-467.
36. Liu J, et al. (2011) Relationship between biomarkers of cigarette smoke exposure and biomarkers of inflammation, oxidative stress, and platelet activation in adult cigarette smokers. Cancer Epidemiol Biomarkers Prev 20(8):1760-1769.
37. Jefferis BJ, et al. (2010) Secondhand smoke (SHS) exposure is associated with circulating markers of inflammation and endothelial function in adult men and women. Atherosclerosis 208(2):550-556.
38. Campos M, et al. (2011) Genetic determinants of plasma von Willebrand factor antigen levels: A target gene SNP and haplotype analysis of ARIC cohort. Blood 117(19):5224-5230.
39. Campos M, et al. (2012) Influence of single nucleotide polymorphisms in factor VIII and von Willebrand factor genes on plasma factor VIII activity: The ARIC Study. Blood 119(8):1929-1934.
40. Sadler JE (2009) von Willebrand factor assembly and secretion. J Thromb Haemost 7(Suppl 1):24-27.
41. Orstavik KH, Kornstad L, Reisner H, Berg K (1989) Possible effect of secretor locus on plasma concentration of factor VIII and von Willebrand factor. Blood 73(4):990-993.
42. O'Donnell J, Boulton FE, Manning RA, Laffan MA (2002) Genotype at the secretor blood group locus is a determinant of plasma von Willebrand factor level. Br J Haematol 116(2):350-356.
43. Morange PE, et al. (2005) Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: Results from the Stanislas cohort. Br J Haematol 128(1):91-99.
44. Kario K, et al. (1998) Endothelial cell damage and angiotensin-converting enzyme insertion/deletion genotype in elderly hypertensive patients. J Am Coll Cardiol 32(2):444-450.
45. Nossent AY, et al. (2010) Functional variation in the arginine vasopressin 2 receptor as a modifier of human plasma von Willebrand factor levels. J Thromb Haemost 8(7):1547-1554.
46. Frazer KA, Murray SS, Schork NJ, Topol EJ (2009) Human genetic variation and its contribution to complex traits. Nat Rev Genet 10(4):241-251.
47. Manolio TA, et al. (2009) Finding the missing heritability of complex diseases. Nature 461(7265):747-753.
48. Wright FA, et al. (2011) Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2. Nat Genet 43(6):539-546.
49. Hinrichs AL, Suarez BK (2011) Incorporating linkage information into a common disease/rare variant framework. Genet Epidemiol 35(Suppl 1):S74-S79.